Physicians, subsequence and consequence

Journal of Neurology Neurosurgery and Psychiatry

Volumn 67, Issue 3, 1999, Pages 282-289

  McDonald, W I ^a,b,c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

^c ROYAL COLLEGE OF PHYSICIANS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID;

CONFERENCE PAPER; HUMAN; MULTIPLE SCLEROSIS; NEUROOPHTHALMOLOGY; OPTIC NERVE DISEASE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK; UNITED KINGDOM; NEUROLOGY; OPTIC NEURITIS; PHYSICIAN; REVIEW;

HUMANS; MULTIPLE SCLEROSIS; NEUROLOGY; OPTIC NEURITIS; PHYSICIANS;

EID: 0032799824     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.67.3.282     Document Type: Review

References (84)

1. Lucas C. An essay on waters. 3 Vols. London: A Millar, 1756.
2. Johnson S. Review of Dr Lucas's essay on waters. Literary Magazine 1756;ii:39.
3. Symonds CP, Meadows SP. Compression of the spinal cord in the neighbourhood of the foremen magnum. Brain 1937;60:52-84.
4. Meadows SP. Intracavernous aneurysms of the internal carotid artery: their clinical features and natural history. Arch Ophthalmol 1959;62:566-74.
5. Meadows SP. Unusual clinical features and modes of presentation in pituitary adenoma, including pituitary apoplexy. Neuroophthalmology 1968;4:178-89.
6. Meadows SP. Blindness due to occlusive arterial disease. Trans Ophthalmol Soc UK 1965;85:251-8.
7. Meadows SP. Doyne Memorial Lecture (1969): Retrobulbar and optic neuritis in childhood and adolescence. Transactions of the Ophthalmological Society of the UK 1969;89: 603-38.
8. Kennedy C, Carter S. Relation of optic neuritis to multiple sclerosis in children. Pediatrics 1961;28:377-87.
9. Hierons R, Lyle TK. Bilateral retrobulbar optic neuritis. Brain 1959;82:56-67.
10. Parkin PJ, Hierons R, McDonald WI. Bilateral optic neuritis: a long-term follow-up. Brain 1984;107:951-64.
11. Kriss A, Francis DA, Cuendet F, et al. Recovery after optic neuritis in childhood. J Neurol Neurosurg Psychiatry 1988;51:1253-8.
12. Haller P, Patzold U. Die Optikusneuritis im Kiudersalter. Forschritte der Neurologle und Psychiatrie 1979;47:209-16.
13. Luccinetti CF, Kiers L, O'Duffy A, et al. Risk factors for developing multiple sclerosis after childhood optic neuritis. Neurology 1997;49:1413-18.
14. MacKarell P. Interior journey and beyond: an artist's view of optic neuritis. In: RF Hess, Plant GT, eds. Optic neuritis. Cambridge: Cambridge University Press, 1986: 283-93.
15. McDonald WI, Barnes D. The ocular manifestations of multiple sclerosis. I. Abnormalities of the afferent visual system. J Neurol Neurosurg Psychiatry 1992;55:747-52.
16. Earl CJ, Martin B. Prognosis in optic neuritis related to age. Lancet 1967;i:74-6.
17. Gould ES, Bird AC, Leaver, PK, et al. Treatment of optic neuritis by retrobulbar injection of triamcinolone. BMJ 1977;i:1495-7.
18. Beck W, Cleary DA, Anderson MM, et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. N Engl J Med 1992;326:581-8.
19. Rodriguez M, Siva A, Cross SA, et al. Optic neuritis: a population based study in Olmsted County, Minnesota. Neurology 1995;45:244-50.
20. Miller DH, Newton MR, van der Poel JC, et al. Magnetic resonance imaging of the optic nerve in optic neuritis. Neurology 1988;38:175-9.
21. Kapoor R, Miller DH, Jones SJ, et al. Effects of intravenous methylprednisolone on outcome in MRI-based prognostic subgroups in acute optic neuritis. Neurology 1998;50: 230-7.
22. Bradley WG, Whitty CWM. Acute optic neuritis: prognosis for development of multiple sclerosis. J Neurol Neurosurg Psychiatry 1968;31:10-18.
23. Francis DA, Compston DAS, Batchelor JR, et al. A reassessment of the risk of multiple sclerosis developing in patients with optic neuntis after extended follow up. J Neurol Neurosurg Psychiatry 1987;50:758-65.
24. Rizzo JF, Lessell S. Risk of developing multiple sclerosis after uncomplicated optic neuritis: a long term prospective study. Neurology 1988;38:185-90.
25. Sandberg-Wollheim M, Bynke H, Cronqvist S, et al. A longterm prospective study of optic neuritis: evaluation of risk factors. Ann Neurol 1990;27:386-93.
26. Firth D. The case of Augustus D'Este. Cambridge: Cambridge University Press, 1948.
27. Carswell R. Pathological anatomy: illustrations of the elementary forms of the disease. London: Longmans, 1838.
28. Compston DAS. The dissemination of multiple sclerosis. J R Coll Physicians Lond 1990;24:207-18.
29. McKenzie W. A practical treatise on diseases of the eye. 3rd ed. London: Longman, 1840.
30. Ivers RR, Goldstein NP. Multiple sclerosis: a current appraisal of symptoms and signs. Proc Mayo Clin 1963;38: 457-66.
31. Shibasaki H, McDonald WI, Kuroiwa Y. Racial modification of clinical picture of multiple sclerosis: comparison between British and Japanese patients. J Neurol Sci 1981;49:253-71.
32. Lumsden CE. The pathology of multiple sclerosis. In: Vinken PJ, Bruyn GW, eds. Handbook of clinical neurology: multiple sclerosis and other denyelinating diseases. Amsterdam: North-Holland, 1970;9:217-309.
33. Ulrich J, Groebke-Lorenz W. The optic nerve in multiple sclerosis: a morphological study with retrospective clinicopathological correlations. Neuroophthalmology 1983;3: 149-59.
34. Kurland LT, Beebe GW, Kurtzke JF, et al. Studies on the natural history of multiple sclerosis. 2. The progression of optic neuritis to multiple sclerosis. Acta Neurol Scand 1966; 42(suppl 19):157-76.
35. Taub RG, Rucker CW. The relationship of retrobulbar neuritis to multiple sclerosis. Am J Ophthalmol 1954;37:494-7.
36. Collis WJ. Acute unilateral retrobulbar neuritis. Arch Neurol 1965;13:409-12.
37. Cohen MM, Lessell S, Wolf PA. A prospective study of the risk of developing multiple sclerosis in uncomplicated optic neuritis. Neurology (Minneapolis) 1979;29:208-13.
38. Hutchinson WM. Acute optic neuritis and the prognosis for multiple sclerosis. J Neurol Neurosurg Psychiatry 1976;39: 283-9.
39. Compston DAS, Batchelor JR, Earl CJ, et al. Factors influencing the risk of multiple sclerosis developing in patients with optic neuritis. Brain 1978;101:495-511.
40. Kinnunen E. The incidence of optic neuritis and its prognosis for multiple sclerosis. Acta Neurol Scand 1983;68:371-7.
41. Rischbeith RHC. Retrobulbar neuritis in the state of South Australia. Proc Aust Assoc Neurol 1968;5:573-5.
42. Landy PJ. A prospective study of the risk of developing multiple sclerosis in optic neuritis in a tropical and sub-tropical area. J Neurol Neurosurg Psychiatry 1983;46:659.
43. Landy PJ. The probability of developing multiple sclerosis following an episode of optic neuritis: a prospective study. J Clin Neurosci 1999 (in press).
44. Hely MA, McManis PG, Dorain TJ, et al. Acute optic neuritis: a prospective study of risk factors for multiple sclerosis. J Neurol Neurosurg Psychiatry 1986;49:1125-30.
45. Isayama Y, Takahashi T, Shimoyoma T, et al. Acute optic neuritis and multiple sclerosis. Neurology 1982;32:73-6.
46. Moulin D, Paty DW, Ebers GC. The predictive value of cerebrospinal fluid electrophoresis in possible multiple sclerosis. Brain 1983;106:809-16.
47. Söderström M, Ya-ping J, Hillert J, et al. Optic neuritis. Prognosis for multiple sclerosis from MNRI, CSF and HLA findings. Neurology 1998;50:708-14.
48. Lightman S, McDonald WI, Bird AC, et al. Retinal venous sheathing in optic neuritis: its significance for the pathogenesis of multiple sclerosis. Brain 1987;110:405-14.
49. Miller DH, Albert PS, Barkhof F, et al. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. Ann Neurol 1996;39:6-16.
50. Miller DH, Ormerod IEC, McDonald WI, et al. The early risk of multiple sclerosis after optic neuritis. J Neurol Neurosurg Psychiatry 1988;51:1569-71.
51. O'Riordon JI, Thompson AJ, Kingsley DPE, et al. The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10 year follow up. Brain 1998;121:495-503.
52. Morrissey SP, Borruat FX, Miller DH, et al. Bilateral simultaneous optic neuropathy in adults: clinical, imaging, serological, and genetic studies. J Neurol Neurosurg Psychiatry 1995;58:70-4.
53. Stewart WA, Hall LD, Berry K, et al. Correlation between NMR scan and brain slice data in multiple sclerosis. Lancet 1984;ii:412.
54. Ormerod IEC, Miller DH, McDonald WI. The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions: a quantitative study. Brain 1987;110:1579-616.
55. Katz D, Taubenberger JK, Cannella B, et al. Correlation between MRI findings and lesion development in chronic active multiple sclerosis. Ann Neurol 1993;34:661-9.
56. Nesbit GM, Forbes GS, Scheithauer BW, et al. Multiple sclerosis: histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy. Radiology 1991;180:467-74.
57. Kermode AG, Thomson AJ, Tofts P, et al. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis: pathogenetic and clinical implications. Brain 1990;113:1477-89.
58. Willoughby EW, Grochawski E, Li DKB, et al. Serial magnetic resonance scanning in multiple sclerosis: a second prospective study in relapsing patients. Ann Neurol 1989;25:43-9.
59. Miller DH, Rudge P, Johnson G, et al. Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain 1988;111:927-39.
60. 2 in the brain of patients with severe but stable multiple sclerosis. Magn Reson Med 1988;7:43-55.
61. Barnes D, McDonald WI, Landon DN, et al. The characterization of experimental gliosis by quantitative nuclear magnetic resonance imaging. Brain 1988;111:83-94.
62. Barnes D, Munro PMG, Youl BD, et al. The longstanding MS lesion. A quantitative MRI and electron microscopic study. Brain 1991;114:1271-80.
63. Davie CA, Hawkins CP, Barker GJ, et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain 1994;117:49-8.
64. Youl BD, Turano G, Miller DH, et al. The pathophysiology of acute optic neuritis: an association of gadolinium leakage with clinical and electrophysiological deficits. Brain 1991; 114:2437-50.
65. McDonald WI. The effects of experimental demyelination on conduction in peripheral nerve: a histological and electrophysiological study. II electrophysiological observations. Brain 1963;86:501-24.
66. McDonald WI, Sears TA. The effects of experimental demyelination on conduction in the central nervous system. Brain 1970;93:583-98.
67. Redford DJ, Kapoor R, Smith KJ. Nitric oxide donors reversibly block axonal conduction; demyelinated axons are especially susceptible. Brain 1997;120:2149-57.
68. England JD, Gamboni F, Levinson SR, et al. Changed distribution of sodium channels along demyelinated axons. Proc Natl Acad Sci USA 1990;87:6777-801.
69. Black JA, Felts P, Smith KJ, et al. Distribution of sodium channels in chronically demyelinated spinal cord axons: immuno-ultrastructural localisation and electrophysiological observations. Brain Res 1991;544:59-70.
70. Bostock H, Sears TA. The internodal axon membrane: electrical excitability and continuous conduction in segmental demyelination. J Physial 1978;280:273-301.
71. Smith KJ, Felts PA, Baker TA. Conduction properties of glial-ensheathed and sparsely ensheathed central demyelinated axons. Ann Neurol 1994;36:287. [abstract].
72. Moll C, Mourre C, Lazdunski M, et al. Increase of sodium channels in demyelinated lesions of multiple sclerosis. Brain Res 1991;556:311-16.
73. Prineas J, Connell F. Remyelination in multiple sclerosis. Ann Neurol 1979;5:22-31.
74. Ozawa K, Suchanek G, Breitschopf H, et al. Patterns of oligodendroglial pathology in multiple sclerosis. Brain 1994; 117:1311-22.
75. Jones SJ. Visual evoked potentials after optic neuritis. Effect of time interval, age and disease dissemination. J Neurol 1993;240:489-94.
76. Beck RW, Cleary PA. The Optic Neuritis Study Group. Optic neuritis treatment trial. Arch Ophthalmol 1993;111: 773-5.
77. Beck RW, Cleary PA, Traub JD, et al. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. N Engl J Med 1993;329:1764-9.
78. Silberberg DH. Corticosteroids and optic neuritis. N Engl J Med 1993;329:1808-10.
79. Beck RW, The optic neuritis treatment trial: three year follow up results. Arch Ophthalmol 1995;113:136.
80. Matthews JR. Quantification and the quest for medical certainty. Princeton: Princeton University Press, 1995.
81. Fisher RA. The design of experiments. Edinburgh: Oliver and Boyd, 1935.
82. Streptomycin treatment of pulmonary tuberculosis. A Medical Research Council investigation. BMJ 1948;ii: 769-82.
83. Weinshenker BG, Carriere W, Baskerville J, et al. The natural history of multiple sclerosis: a geographically based study. IV. Applications to planning and interpretation of clinical therapeutic trials. Brain 1991;114:1057-67.
84. Runmarker B, Andersen O. Prognostic factors in a multiple sclerosis incident cohort with 25 years of follow up. Brain 1993;116:117-34.